Was the Genesco (GCO) share grant to Matthew M. Bilunas a market purchase or a compensation grant?

The 3,905-share transaction for Matthew M. Bilunas is a grant/award acquisition, not a market purchase. It represents restricted stock granted under Genesco's Fourth Amended and Restated 2020 Equity Incentive Plan, with a reported transaction price of $0.0000 per share.

Genesco director granted 3,905 restricted shares

Q: What type of equity award did Genesco (GCO) grant to director Matthew M. Bilunas?

The award to Matthew M. Bilunas is restricted stock in the form of 3,905 shares of Genesco common stock. It was granted under the Fourth Amended and Restated 2020 Equity Incentive Plan, which governs the company's stock-based compensation to eligible participants.

Q: What does the reported price of $0.0000 on Genesco (GCO) Form 4 signify?

The Form 4 reports a per-share price of $0.0000 for the 3,905 shares granted to Matthew M. Bilunas. This reflects that the transaction is a restricted stock award under the equity incentive plan, rather than a cash purchase of shares in the open market.

Bilunas Matthew M reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Bilunas Matthew M reported acquisition or exercise transactions in this Form 4 filing.

Genesco Inc director Matthew M. Bilunas received a grant of 3,905 shares of common stock on 2026-07-24 as restricted stock under the company's Fourth Amended and Restated 2020 Equity Incentive Plan, increasing his directly held stake to 19,006 shares.

Insider Trade Summary

Grant/Award: 3,905 shares

Grant/Award 1 txn

Insider Bilunas Matthew M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F1	3,905	$0.00	$0.00

Holdings After Transaction: Common Stock — 19,006 shares (Direct)

Footnotes (1)

F1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.

Key Figures

Restricted stock granted: 3,905 shares Shares held after transaction: 19,006 shares Reported transaction price: $0.0000 per share +1 more

4 metrics

Restricted stock granted 3,905 shares Grant of common stock on 2026-07-24 to director Matthew M. Bilunas

Shares held after transaction 19,006 shares Directly held Genesco common stock by Matthew M. Bilunas following the grant

Reported transaction price $0.0000 per share Per-share price reported for the 3,905-share restricted stock award

Acquisition transactions reported 1 Non-derivative acquisition (grant/award) transactions in this Form 4

Key Terms

restricted stock, Fourth Amended and Restated 2020 Equity Incentive Plan, grant/award acquisition

3 terms

restricted stock financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Fourth Amended and Restated 2020 Equity Incentive Plan financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan."

grant/award acquisition financial

"transaction_action: grant/award acquisition for 3,905 shares of common stock."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Genesco (GCO) report for Matthew M. Bilunas?

Matthew M. Bilunas, a director of Genesco Inc (GCO), received a grant of 3,905 shares of common stock on 2026-07-24. The award consists of restricted stock issued under the company's Fourth Amended and Restated 2020 Equity Incentive Plan as part of his equity compensation.

How many Genesco (GCO) shares does Matthew M. Bilunas hold after this Form 4?

Following the reported grant, Matthew M. Bilunas directly holds 19,006 shares of Genesco common stock. This total includes the newly granted 3,905 restricted shares issued on 2026-07-24 under the company's Fourth Amended and Restated 2020 Equity Incentive Plan.

What type of equity award did Genesco (GCO) grant to director Matthew M. Bilunas?

The award to Matthew M. Bilunas is restricted stock in the form of 3,905 shares of Genesco common stock. It was granted under the Fourth Amended and Restated 2020 Equity Incentive Plan, which governs the company's stock-based compensation to eligible participants.

What does the reported price of $0.0000 on Genesco (GCO) Form 4 signify?

The Form 4 reports a per-share price of $0.0000 for the 3,905 shares granted to Matthew M. Bilunas. This reflects that the transaction is a restricted stock award under the equity incentive plan, rather than a cash purchase of shares in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/24/2026 - 04:02 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bilunas Matthew M

(Last)

(First)

(Middle)

C/O GENESCO INC.

535 MARRIOTT DRIVE

(Street)

NASHVILLE

TENNESSEE

37214

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENESCO INC [ GCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/24/2026		A		3,905⁽¹⁾	A	$0.00	19,006	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.

	Scott E. Becker, Attorney-in-Fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR